Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Finranks

Kompaniya

  • Biz haqimizda

Biz bilan bog'lanish

  • [email protected]

Bizni kuzating

  • Instagram
  • Telegram
  • LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari
  • Bosh sahifa
  • Bozorlar
  • Skriner
  • Yangiliklar
  • Biz haqimizda
  1. Home
  2. ALC
A

Alcon Inc. (ALC)

NYQ – Real vaqt narxi. Valyuta: USD

73.34

-1.13 (-1.52%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

73.41

+0.07 (0.10%)

Bozordan keyin: Mar 27, 2026, 6:27 PM EDT

  • Umumiy
  • Yangiliklar
  • Grafik
  • Hisobotlar
  • Dividendlar
  • Kutilma
  • Egalik
  • Profil
Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads
17.03.2026

Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads

Alcon is reaffirmed as a buy, supported by robust macro demand in eyecare and a strong product pipeline despite abandoning the STAAR Surgical acquisition. ALC demonstrates potential resilience versus market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. While ALC lags peers in some profitability metrics and offers only an annual 0.43% dividend, its low payout ratio and dividend growth provide some support to the dividend case.

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
16.03.2026

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement.

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
10.03.2026

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education
09.03.2026

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education

New English and Spanish editions of Understanding and Living with Glaucoma and first-ever Spanish audiobook aim to reach high-risk Hispanic communities Resources will be available during Glaucoma Awareness Week beginning March 9th SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking patients and families in the United States. Through Alcon's support, GRF will release an updated English and Spanish editions of its widely used “Understanding and Living with Glaucoma” booklet and introduce the first-ever Spanish audiobook version of this essential resource.

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
02.03.2026

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

Here is how Alcon (ALC) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.

Alcon Surpasses 175 Million IOLs Implanted Globally
02.03.2026

Alcon Surpasses 175 Million IOLs Implanted Globally

GENEVA--(BUSINESS WIRE)--Alcon Surpasses 175 Million IOLs Implanted Globally.

Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript
25.02.2026

Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript

Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript

Videolar

No Data

There is no data to display

Press-relizlar

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
16.03.2026

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement.

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education
09.03.2026

Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education

New English and Spanish editions of Understanding and Living with Glaucoma and first-ever Spanish audiobook aim to reach high-risk Hispanic communities Resources will be available during Glaucoma Awareness Week beginning March 9th SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking patients and families in the United States. Through Alcon's support, GRF will release an updated English and Spanish editions of its widely used “Understanding and Living with Glaucoma” booklet and introduce the first-ever Spanish audiobook version of this essential resource.

Alcon Surpasses 175 Million IOLs Implanted Globally
02.03.2026

Alcon Surpasses 175 Million IOLs Implanted Globally

GENEVA--(BUSINESS WIRE)--Alcon Surpasses 175 Million IOLs Implanted Globally.

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
24.02.2026

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

GENEVA--(BUSINESS WIRE)--Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales.